Financhill
Sell
18

CATX Quote, Financials, Valuation and Earnings

Last price:
$1.94
Seasonality move :
6.91%
Day range:
$2.01 - $2.21
52-week range:
$2.01 - $19.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.79x
P/B ratio:
0.54x
Volume:
979.1K
Avg. volume:
600.6K
1-year change:
-82.1%
Market cap:
$157.7M
Revenue:
--
EPS (TTM):
-$1.20

Earnings Data

Next earnings date for CATX
May 15
2025
Most recent earnings per share
-$0.61
Missed by $0.35
(Mar 26/2025)
Consensus Estimate
-$0.26
(Mar 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CATX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $126K -- -- -$0.31 --
05/15/2025 Q1 $125.1K -- -- -$0.27 --
03/26/2025 Q4 $302.5K -- -$0.61 -$0.26 -$0.35
11/12/2024 Q3 $237.9K -- -$0.21 -$0.20 -$0.01
08/12/2024 Q2 $135.6K -- -$0.18 -- --
05/15/2024 Q1 $68.8K -- -$0.20 -- --
03/28/2024 Q4 $2.1M -- -$0.87 -- --
11/14/2023 Q3 $2.2M -- -$0.37 -- --
08/11/2023 Q2 $2.6M -- -$0.40 -- --
05/16/2023 Q1 -- -- -- -- --
12/31/2022 Q4 -- -- -$0.02 -- --
11/10/2022 Q3 -- $1.7M -$0.30 -- --
06/30/2022 Q2 -- $2.5M -$0.10 -- --
03/31/2022 Q1 -- $2.9M -$0.10 -- --
12/31/2021 Q4 -- $2.8M -$0.10 -- --
09/30/2021 Q3 -- $2.6M -$0.20 -- --
06/30/2021 Q2 -- $2.7M -$0.10 -- --
03/31/2021 Q1 -- $2.6M -$0.10 -- --
12/31/2020 Q4 -- $2.4M -$0.10 -- --
09/30/2020 Q3 -- $2.4M -$0.10 -- --
06/30/2020 Q2 -- $2.3M -$0.20 -- --
03/31/2020 Q1 -- $2.9M -$0.10 -- --
12/31/2019 Q4 -- $2.2M -$0.10 -- --
09/30/2019 Q3 -- $2.3M -$0.10 -- --
06/30/2019 Q2 -- $1.9M -$0.20 -- --
03/31/2019 Q1 -- $1.9M -$0.20 -- --
12/31/2018 Q4 -- $1.9M -$0.20 -- --
09/30/2018 Q3 -- $1.6M -$0.20 -- --
06/30/2018 Q2 -- $1.6M -$0.43 -- --
03/31/2018 Q1 -- $1.6M -$0.24 -- --
12/31/2017 Q4 -- $1.5M -$0.30 -- --
09/30/2017 Q3 -- $1.2M -$0.30 -- --
06/30/2017 Q2 -- $1.4M -$0.30 -- --
03/31/2017 Q1 -- $1.3M -$0.25 -- --
12/31/2016 Q4 -- $1M -$0.30 -- --
09/30/2016 Q3 -- $1.1M -$0.30 -- --
06/30/2016 Q2 -- $1.1M -$0.30 -- --
03/31/2016 Q1 -- $1.2M -$0.20 -- --
12/31/2015 Q4 -- $1.2M -$0.20 -- --
09/30/2015 Q3 -- $1.3M -$0.20 -- --
06/30/2015 Q2 -- $1.3M -$0.20 -- --

Perspective Therapeutics Earnings Questions

  • How Much did Perspective Therapeutics Generate in Revenue Last Quarter?

    Perspective Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Perspective Therapeutics Beat Earnings Last Quarter?

    Perspective Therapeutics announced earnings per share of -$0.61 which represents a miss of analyst forecast a -$0.26 per share.

  • Is Perspective Therapeutics Profitable?

    Perspective Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Perspective Therapeutics EPS Next Year?

    Perspective Therapeutics's earnings are forecast to decrease from -$1.23 per share to -$0.85 per share next year representing a decrease of -9.06%.

  • When is Perspective Therapeutics's Earnings Date?

    Perspective Therapeutics's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 19.56% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 14.62% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 4.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock